This interview with Dr Ramaprasad Srinivasan from the National Cancer Institute in Bethesda, USA, discusses the management of sarcomatoid renal cell carcinoma (RCC), papillary RCC, and hereditary RCC, such as hereditary leiomyomatosis RCC (HLRCC).

Watch the interview with Dr Srinivasan on Practice Update here